Alecensa 150 MG capsule UU 240S
Ended Awarded
- Contract number
- SPE2DB25FPRP8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,707
Award facts
- Contract value 100% obligated
- $12,707.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,707.13 to DMS Pharmaceutical Group Inc. on September 25, 2025, for the supply of Alecensa 150 mg capsules (240-count units). This award represents a firm fixed-price delivery order with an ultimate completion date of October 17, 2025, and will be fulfilled from the vendor's Park Ridge, Illinois location. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its status as a woman-owned small business.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the issuance of firm fixed-price delivery orders for comprehensive pharmaceutical products supporting military health facilities worldwide. Alecensa, a branded oncology medication, falls within the contract's scope of specialty pharmaceutical products including prescription drugs, biologics, and medical consumables. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, consistently securing delivery orders for diverse medications ranging from contraceptives to cancer treatments across Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FPRP8?
SPE2DB25FPRP8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FPRP8 worth?
The government has obligated $12,707 on SPE2DB25FPRP8.
Is contract SPE2DB25FPRP8 an order under another contract?
Yes. SPE2DB25FPRP8 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPRP8 competed?
The extent of competition for SPE2DB25FPRP8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award